Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma

Published:2010-10-13 Issue:1 Volume:8 Page:
ISSN:1477-7819
Container-title:World Journal of Surgical Oncology
language:en
Short-container-title:World J Surg Onc

Author:

Foster Jason M,Radhakrishna Uppala,Govindarajan Venkatesh,Carreau Joseph H,Gatalica Zoran,Sharma Poonam,Nath Swapan K,Loggie Brian W

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1186/1477-7819-8-88.pdf

Reference29 articles.

1. Sequist LV, Joshi VA, Janne PA, Bell DW, Fidias P, Lindeman NI, Louis DN, Lee JC, Mark EJ, Longtine J, Verlander P, Kucherlapati R, Meyerson M, Haber DA, Johnson BE, Lynch TJ: Epidermal growth factor receptor mutation testing in the care of lung cancer patients. Clin Cancer Res. 2006, 12: 4403s-4408s. 10.1158/1078-0432.CCR-06-0099.

2. Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T: Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res. 2004, 64: 8919-8923. 10.1158/0008-5472.CAN-04-2818.

3. Lee CM, Lee RJ, Hammond E, Tsodikov A, Dodson M, Zempolich K, Gaffney DK: Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis. Gynecol Oncol. 2004, 93: 209-214. 10.1016/j.ygyno.2004.01.006.

4. Riviere A, Becker J, Loning T: Comparative investigation of c-erbB2/neu expression in head and neck tumors and mammary cancer. Cancer. 1991, 67: 2142-2149. 10.1002/1097-0142(19910415)67:8<2142::AID-CNCR2820670823>3.0.CO;2-8.

5. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M: EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004, 304: 1497-1500. 10.1126/science.1099314.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spindle Cell Lesions with Oncogenic EGFR Kinase Domain Aberrations: Expanding the Spectrum of Protein Kinase–Related Mesenchymal Tumors;Modern Pathology;2024-09

2. Malignant peritoneal mesothelioma interactome with 417 novel protein–protein interactions;BJC Reports;2024-05-24

3. A multiplex, prime editing framework for identifying drug resistance variants at scale;2023-07-30

4. Genetic alterations shaping tumor response to anti-EGFR therapies;Drug Resistance Updates;2022-09

5. Molecular Pathways in Peritoneal Mesothelioma: A Minireview of New Insights;Frontiers in Oncology;2022-02-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3